The federal government announced a new round of Canada Research Chairs in November 2024, including three based at The Ottawa Hospital.
Dr. Bernard Thébaud, neonatologist and senior scientist in OHRI’s Regenerative Medicine Program, was appointed Tier 1 Canada Research Chair in Lung Stem Cell Biology and Regeneration. Dr. Thébaud’s team, which is also affiliated with CHEO Research Institute, is focused on translating innovative cell and gene therapy research into new treatments for premature babies.